Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Weight Loss

GLP-1 Drugs and Anorexia: How Telehealth Loopholes Are Endangering the Most Vulnerable Patients

Telehealth platforms are prescribing GLP-1 weight-loss drugs to patients with anorexia with little oversight — and the consequences are proving fatal.

Latin Times · 5h ago

A Plan to Eat Teflon for Weight Loss Rested on 1960s Rats That Slimmed Down by Accident

An Ig Nobel paper proposed eating Teflon to feel full, citing old DuPont rat tests. Now several states have banned the same coating from new pans.

Medical Daily · 18h ago

Number of Scots receiving weight loss jabs on NHS revealed

THE number of Scots who have received jabs to help them lose weight on the NHS after the drugs were approved three years ago has been revealed ...

The National (Scotland) · Oct 15

From analysis to the latest developments in health,
read the most diverse news in one place.

Walmart Makes Ozempic and Mounjaro Free for Workers with Type 2 Diabetes in 2027, Excluding Weight Loss Use

Walmart will make Ozempic and Mounjaro free in 2027 for workers with Type 2 diabetes who get prior approval. Use for weight loss alone is not covered.

Medical Daily · Oct 15

What 2 Weeks in a Boarding Kennel Does to a Dog's Appetite and Behaviour

Why the Kennel Environment Disrupts a Dog's BaselineDogs are creatures of associative routine. Their nervous systems are calibrated to the specific sounds, smells, and rhythms of the household they live in. A boarding kennel replaces all of that simultaneously: the scent profile changes, the vocal landscape changes, the light cycle…

Times Life · Oct 15

Roche Bets Up to $1.16 Billion on Rona's Obesity Drug That Aims to Cut Fat but Spare Muscle

Roche licensed Rona's experimental ALK7 obesity drug in a deal worth up to $1.16 billion. No human data are out yet. What it means for weight loss.

Medical Daily · Oct 15

GLP-1 Drugs Now Start as Low as $149 — But There’s a Catch

For Americans who have been priced out of popular weight-loss medications, a $149 monthly price tag sounds like welcome news. After years of seeing drugs...

Saving Advice · Oct 14

Read news from The Economist, FT, and more,
with one subscription

Can You Eat Your Favourite Foods and Stay Healthy?

Imagine starting Monday with a promise to eat healthy. You skip your favourite breakfast, avoid rice at lunch, say no to snacks in the evening, and resist dessert after dinner. By the end of the week, you are tired of following rules and craving the very foods you tried to…

MyLifeXP · Oct 14

5 Benefits of Clove Water Nobody Talks About

A glass of clove water before breakfast may seem like a simple way to support your health, but is drinking it on an empty stomach really beneficial? Cloves contain eugenol, a natural compound studied for its antioxidant and antimicrobial properties. However, the benefits of clove water are not as well…

MyLifeXP · Oct 14

Weight loss jabs linked to unusual health problem in new study

Experts say potential side effects no reason to stop using jabs

The Independent UK · Oct 13

Kelly Osbourne Recalls Writing 'Please Help Me' on Candle at Ozzy's Grave Amid Her Weight Loss Struggles

Kelly Osbourne has described how grief after her father Ozzy's death affected her eating and wellbeing, saying she sought help through a candle ritual at his grave

International Business Times UK · Oct 12

'I Was as Shocked as Anyone': Kelly Osbourne Reveals Two-Stone Weight Gain After BRIT Awards Photos

Kelly Osbourne says she was shocked by her own BRIT Awards photos. Now, she has revealed how much weight she has gained and what caused her earlier weight loss.

International Business Times UK · Oct 12

Kelly Osbourne Reveals Dramatic 28-Lb Weight Gain After BRITs Photos Left Her ‘As Shocked As Everyone Else’

Kelly Osbourne revealed she gained 28 pounds in six months after photos from the BRIT Awards sparked widespread concern about her appearance.

Bored Panda · Oct 11

Women with PMOS should get subsidised weight-loss drugs, Australian advocates say

With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-label

The Guardian - AU · Oct 9

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Oct 8

Dementia Patients Overweight or Obese at Diagnosis Had Up to 27% Lower Death Risk, Raising Caregiver Nutrition Questions

A national study of 4,523 U.S. adults with dementia linked higher weight at diagnosis to longer survival. Here is what it means for caregivers.

The Independent UK · Oct 7

Why weight loss drug adverts have been banned for the first time in the UK

IN FULL

The Independent UK · Oct 6

First ads for ‘powerful’ weight loss pills banned by watchdog

The ASA warned that advertisers needed to consider the overall impression of an advert

Evening Standard · Oct 6

Watchdog bans first ads for oral weight loss medicines

The ASA said the rulings were part of wider action to tackle irresponsible ads for weight loss medicines.

Get all your
news in one place.

100's of premium titles.
One news app.

MyLifeXP · Oct 5

Hair Loss Was Just the Start? The Nail Truth

Hair shedding became one of the most talked-about cosmetic complaints linked with GLP-1 medicines. Now, researchers have found another change that is drawing attention: nail problems. A study presented at the 2026 European Academy of Dermatology and Venereology (EADV) Congress found that nail detachment was reported by 39% of GLP-1…

Medical Daily · Oct 4

GLP-1 Users Reported Nail Detachment Four Times as Often as Nonusers in an Early International Dermatology Survey

GLP-1 users reported nail detachment four times as often as nonusers in an early EADV survey. See what the nail and hair data show and do not prove.

Medical Daily · Oct 3

Rhode Island Medicaid Ends Coverage of Wegovy, Zepbound, and Other GLP-1 Drugs Prescribed Only for Weight Loss

Rhode Island Medicaid stopped covering Wegovy, Zepbound, Saxenda, and Foundayo for weight loss on Oct. 1, 2026. Diabetes coverage continues. Here is what members should know.

Medical Daily · Oct 3

Lilly's Foundayo Pill Linked to 57% Lower Predicted Diabetes Risk in ATTAIN-1 Modeling, but No Cases Were Counted

A Lilly-funded modeling analysis tied Foundayo to a 57% lower predicted 10-year diabetes risk. No actual diabetes cases were counted in the study.

Medical Daily · Oct 2

Peer-Reviewed Retatrutide Data Show 23.4% Weight Loss in Adults with Diabetes and BMI of 35 or Higher

Full Lancet results for Lilly's retatrutide show 23.4% weight loss in adults with type 2 diabetes and a BMI of 35 or higher. The drug remains unapproved.

Medical Daily · Oct 2

Participants Taking CagriSema Showed Changed Brain Responses to High-Calorie Food Images in Novo Study as FDA Decision Nears

Novo says brain scans showed CagriSema changed food-cue responses and cut cravings. The data are early, and an FDA decision is expected in late 2026.

Medical Daily · Oct 2

Lilly's Eloralintide Plus Tirzepatide Produced 23.3% Weight Loss in Phase 2 Trial of Adults with Type 2 Diabetes

Lilly's eloralintide plus tirzepatide produced 23.3% weight loss vs 14.8% for tirzepatide alone in a Phase 2 diabetes trial. Here's the catch.

1 2 3 4 5

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.